145 related articles for article (PubMed ID: 38013352)
21. Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers.
Shao T; Xie Y; Shi J; Yang C; Zou H; Li Y; Xu J; Li X
Commun Biol; 2022 Dec; 5(1):1324. PubMed ID: 36463330
[TBL] [Abstract][Full Text] [Related]
22. Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma.
Zhu J; Deng J; Zhang L; Zhao J; Zhou F; Liu N; Cai R; Wu J; Shu B; Qi S
BMC Cancer; 2020 Sep; 20(1):927. PubMed ID: 32993558
[TBL] [Abstract][Full Text] [Related]
23. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis.
Zhang C; Dang D; Cong L; Sun H; Cong X
Cancer Med; 2021 Jul; 10(14):4710-4720. PubMed ID: 34159752
[TBL] [Abstract][Full Text] [Related]
24. Lactylation-related gene signature for prognostic prediction and immune infiltration analysis in breast cancer.
Jiao Y; Ji F; Hou L; Lv Y; Zhang J
Heliyon; 2024 Feb; 10(3):e24777. PubMed ID: 38318076
[TBL] [Abstract][Full Text] [Related]
25. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
[TBL] [Abstract][Full Text] [Related]
26. Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination.
Wang JH; Mao L; Wang J; Zhang X; Wu M; Wen Q; Yu SC
Cell Oncol (Dordr); 2023 Jun; 46(3):465-480. PubMed ID: 36656507
[TBL] [Abstract][Full Text] [Related]
27. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
28. Histone lactylation drives oncogenesis by facilitating m
Yu J; Chai P; Xie M; Ge S; Ruan J; Fan X; Jia R
Genome Biol; 2021 Mar; 22(1):85. PubMed ID: 33726814
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA.
Zhang M; Yang L; Wang Y; Zuo Y; Chen D; Guo X
Sci Rep; 2023 May; 13(1):7299. PubMed ID: 37147395
[TBL] [Abstract][Full Text] [Related]
32. Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients.
Zhong L; Qian W; Gong W; Zhu L; Zhu J
Aging (Albany NY); 2023 Aug; 15(15):7655-7672. PubMed ID: 37543428
[TBL] [Abstract][Full Text] [Related]
33. Analyzing Prognostic Hub Genes in the Microenvironment of Cutaneous Melanoma by Computer Integrated Bioinformatics.
Li G; Zhang J; Liu Y; Cheng X; Sun K; Hong W; Sha K
Comput Intell Neurosci; 2022; 2022():4493347. PubMed ID: 35300397
[TBL] [Abstract][Full Text] [Related]
34. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
35. Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma.
Zhu Z; Li G; Li Z; Wu Y; Yang Y; Wang M; Zhang H; Qu H; Song Z; He Y
Front Immunol; 2022; 13():914612. PubMed ID: 36072600
[TBL] [Abstract][Full Text] [Related]
36. Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy.
Liu J; Luo B; Zhang P; Jiang K; Hou Z; Cao X; Tang J
BMC Cancer; 2023 Aug; 23(1):752. PubMed ID: 37580654
[TBL] [Abstract][Full Text] [Related]
37. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
[TBL] [Abstract][Full Text] [Related]
38. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
[TBL] [Abstract][Full Text] [Related]
39. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
40. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
Yang S; Xu J; Zeng X
Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
